Wednesday, July 18, 2018 8:13:40 AM
AKER - .3579 Pre-market now at .38/.39
Akers Biosciences Jumps 7%, Inks Deal to Widen Sales Coverage to 12 More States of Rapid Test for Heparin-induced Thrombocytopenia
Akers Biosciences Jumps 7%, Inks Deal to Widen Sales Coverage to 12 More States of Rapid Test for Heparin-induced Thrombocytopenia
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
